No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs13129840 |
chr4:142129314-142129315 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs13129853 |
chr4:142129333-142129334 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
3 |
rs550994677 |
chr4:142129362-142129363 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs372078455 |
chr4:142129383-142129384 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs13111980 |
chr4:142129440-142129441 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
6 |
rs544239012 |
chr4:142129447-142129448 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs562332518 |
chr4:142129503-142129504 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs552046157 |
chr4:142129516-142129517 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs62327563 |
chr4:142129517-142129518 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs112449771 |
chr4:142129518-142129519 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs75574072 |
chr4:142129519-142129520 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs191422809 |
chr4:142129522-142129523 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs559939403 |
chr4:142129572-142129573 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs527451590 |
chr4:142129596-142129597 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs17349945 |
chr4:142129632-142129633 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
16 |
rs1435129 |
chr4:142129680-142129681 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
17 |
rs17428238 |
chr4:142129712-142129713 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
18 |
rs184578631 |
chr4:142129715-142129716 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs569134601 |
chr4:142129735-142129736 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs539943998 |
chr4:142129757-142129758 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs13112869 |
chr4:142129769-142129770 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
22 |
rs374467210 |
chr4:142129772-142129773 |
Enhancers Flanking Active TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs567079037 |
chr4:142129826-142129827 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs577308033 |
chr4:142129852-142129853 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs555992006 |
chr4:142129863-142129864 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs574312985 |
chr4:142129889-142129890 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs113113576 |
chr4:142129944-142129945 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs147618687 |
chr4:142130010-142130011 |
Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs377624907 |
chr4:142130032-142130033 |
Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs373796169 |
chr4:142130062-142130063 |
Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs28700051 |
chr4:142130065-142130066 |
Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs142255001 |
chr4:142130096-142130097 |
Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs6851044 |
chr4:142130107-142130108 |
Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
34 |
rs571914584 |
chr4:142130162-142130163 |
Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs373645522 |
chr4:142130187-142130188 |
Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs566839423 |
chr4:142130194-142130195 |
Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs189411646 |
chr4:142130229-142130230 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs560740601 |
chr4:142130236-142130237 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs181612731 |
chr4:142130257-142130258 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs557742425 |
chr4:142130291-142130292 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs549778785 |
chr4:142130311-142130312 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs36217499 |
chr4:142130366-142130367 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs56405369 |
chr4:142130369-142130370 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs200320701 |
chr4:142130377-142130378 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs397995602 |
chr4:142130382-142130383 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs185219858 |
chr4:142130397-142130398 |
Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs533134689 |
chr4:142130459-142130460 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs551905157 |
chr4:142130462-142130463 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs112486988 |
chr4:142130503-142130504 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs542870965 |
chr4:142130576-142130577 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|